Annual CFO
-$24.60 M
+$9.18 M+27.17%
December 31, 2021
Summary
- As of February 10, 2025, IDRA annual cash flow from operations is -$24.60 million, with the most recent change of +$9.18 million (+27.17%) on December 31, 2021.
- During the last 3 years, IDRA annual CFO has risen by +$27.32 million (+52.62%).
Performance
IDRA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$3.20 M
+$327.00 K+9.28%
September 30, 2022
Summary
- As of February 10, 2025, IDRA quarterly cash flow from operations is -$3.20 million, with the most recent change of +$327.00 thousand (+9.28%) on September 30, 2022.
- Over the past year, IDRA quarterly CFO has increased by +$1.50 million (+31.88%).
Performance
IDRA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$15.34 M
+$1.50 M+8.89%
September 30, 2022
Summary
- As of February 10, 2025, IDRA TTM cash flow from operations is -$15.34 million, with the most recent change of +$1.50 million (+8.89%) on September 30, 2022.
- Over the past year, IDRA TTM CFO has increased by +$12.78 million (+45.45%).
Performance
IDRA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
IDRA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.2% | +31.9% | +45.5% |
| 3 y3 years | +52.6% | +70.5% | +65.5% |
| 5 y5 years | +55.5% | +73.1% | +65.5% |
IDRA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +42.8% | at high | +60.3% |
| 5 y | 5-year | at high | +80.9% | at high | +236.1% | at high | +190.0% |
| alltime | all time | -204.4% | +124.7% | -109.1% | +451.8% | -165.1% | +260.2% |
Idera Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$3.20 M(-9.3%) | -$15.34 M(-8.9%) |
| Jun 2022 | - | -$3.52 M(-22.8%) | -$16.84 M(-14.0%) |
| Mar 2022 | - | -$4.57 M(+12.7%) | -$19.57 M(-20.4%) |
| Dec 2021 | -$24.60 M(-27.2%) | -$4.05 M(-13.7%) | -$24.60 M(-12.5%) |
| Sep 2021 | - | -$4.70 M(-25.0%) | -$28.13 M(-7.9%) |
| Jun 2021 | - | -$6.26 M(-34.7%) | -$30.52 M(-6.4%) |
| Mar 2021 | - | -$9.59 M(+26.5%) | -$32.62 M(-3.4%) |
| Dec 2020 | -$33.77 M(-24.1%) | -$7.58 M(+6.9%) | -$33.77 M(-7.5%) |
| Sep 2020 | - | -$7.09 M(-15.1%) | -$36.52 M(-9.3%) |
| Jun 2020 | - | -$8.35 M(-22.3%) | -$40.27 M(-3.9%) |
| Mar 2020 | - | -$10.75 M(+4.1%) | -$41.89 M(-5.9%) |
| Dec 2019 | -$44.50 M(-14.3%) | -$10.33 M(-4.7%) | -$44.50 M(-2.5%) |
| Sep 2019 | - | -$10.84 M(+8.7%) | -$45.64 M(-2.0%) |
| Jun 2019 | - | -$9.97 M(-25.3%) | -$46.59 M(-7.8%) |
| Mar 2019 | - | -$13.36 M(+16.4%) | -$50.53 M(-2.7%) |
| Dec 2018 | -$51.92 M(-6.0%) | -$11.47 M(-2.7%) | -$51.92 M(-0.1%) |
| Sep 2018 | - | -$11.79 M(-15.2%) | -$51.94 M(-0.2%) |
| Jun 2018 | - | -$13.90 M(-5.7%) | -$52.04 M(-0.6%) |
| Mar 2018 | - | -$14.75 M(+28.2%) | -$52.36 M(-5.2%) |
| Dec 2017 | -$55.26 M(+95.9%) | -$11.50 M(-3.2%) | -$55.26 M(+41.6%) |
| Sep 2017 | - | -$11.88 M(-16.5%) | -$39.01 M(+3.9%) |
| Jun 2017 | - | -$14.23 M(-19.4%) | -$37.56 M(+13.9%) |
| Mar 2017 | - | -$17.65 M(-471.8%) | -$32.99 M(+17.0%) |
| Dec 2016 | -$28.20 M(-34.4%) | $4.75 M(-145.5%) | -$28.20 M(-32.2%) |
| Sep 2016 | - | -$10.44 M(+8.0%) | -$41.60 M(-3.1%) |
| Jun 2016 | - | -$9.66 M(-24.9%) | -$42.93 M(-0.5%) |
| Mar 2016 | - | -$12.86 M(+48.5%) | -$43.13 M(+0.3%) |
| Dec 2015 | -$42.99 M(+37.2%) | -$8.66 M(-26.4%) | -$42.99 M(-2.0%) |
| Sep 2015 | - | -$11.76 M(+19.3%) | -$43.84 M(+9.2%) |
| Jun 2015 | - | -$9.86 M(-22.4%) | -$40.13 M(+10.2%) |
| Mar 2015 | - | -$12.71 M(+33.6%) | -$36.43 M(+16.3%) |
| Dec 2014 | -$31.32 M(+82.8%) | -$9.51 M(+18.1%) | -$31.32 M(+19.2%) |
| Sep 2014 | - | -$8.05 M(+30.8%) | -$26.27 M(+14.8%) |
| Jun 2014 | - | -$6.16 M(-19.0%) | -$22.89 M(+8.8%) |
| Mar 2014 | - | -$7.60 M(+70.4%) | -$21.04 M(+22.8%) |
| Dec 2013 | -$17.14 M(-14.0%) | -$4.46 M(-4.4%) | -$17.14 M(+2.0%) |
| Sep 2013 | - | -$4.67 M(+8.4%) | -$16.80 M(-0.3%) |
| Jun 2013 | - | -$4.31 M(+16.4%) | -$16.84 M(-5.6%) |
| Mar 2013 | - | -$3.70 M(-10.2%) | -$17.84 M(-10.4%) |
| Dec 2012 | -$19.92 M(+3.8%) | -$4.12 M(-12.6%) | -$19.92 M(+2.8%) |
| Sep 2012 | - | -$4.71 M(-11.1%) | -$19.38 M(+1.5%) |
| Jun 2012 | - | -$5.30 M(-8.3%) | -$19.08 M(+2.0%) |
| Mar 2012 | - | -$5.78 M(+61.4%) | -$18.71 M(-2.5%) |
| Dec 2011 | -$19.19 M(-1.9%) | -$3.58 M(-18.9%) | -$19.19 M(-19.6%) |
| Sep 2011 | - | -$4.42 M(-10.4%) | -$23.86 M(+2.3%) |
| Jun 2011 | - | -$4.93 M(-21.2%) | -$23.32 M(+0.0%) |
| Mar 2011 | - | -$6.26 M(-24.1%) | -$23.31 M(+19.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$19.56 M(+25.5%) | -$8.25 M(+113.1%) | -$19.56 M(+14.6%) |
| Sep 2010 | - | -$3.87 M(-21.4%) | -$17.06 M(-2.9%) |
| Jun 2010 | - | -$4.93 M(+96.8%) | -$17.58 M(+38.0%) |
| Mar 2010 | - | -$2.50 M(-56.6%) | -$12.74 M(-18.2%) |
| Dec 2009 | -$15.59 M(-166.1%) | -$5.76 M(+31.2%) | -$15.59 M(+12.8%) |
| Sep 2009 | - | -$4.39 M(+4889.8%) | -$13.82 M(+7.6%) |
| Jun 2009 | - | -$88.00 K(-98.4%) | -$12.85 M(-24.4%) |
| Mar 2009 | - | -$5.35 M(+33.8%) | -$17.00 M(-172.2%) |
| Dec 2008 | $23.56 M(-249.5%) | -$4.00 M(+16.9%) | $23.56 M(+5.5%) |
| Sep 2008 | - | -$3.42 M(-19.5%) | $22.33 M(+2.4%) |
| Jun 2008 | - | -$4.25 M(-112.1%) | $21.80 M(-7.1%) |
| Mar 2008 | - | $35.22 M(-773.8%) | $23.46 M(-248.9%) |
| Dec 2007 | -$15.76 M(-706.4%) | -$5.23 M(+32.4%) | -$15.76 M(-497.7%) |
| Sep 2007 | - | -$3.95 M(+52.8%) | $3.96 M(+5.2%) |
| Jun 2007 | - | -$2.58 M(-35.4%) | $3.77 M(+91.8%) |
| Mar 2007 | - | -$4.00 M(-127.6%) | $1.97 M(-24.4%) |
| Dec 2006 | $2.60 M(-124.7%) | $14.50 M(-449.8%) | $2.60 M(-116.6%) |
| Sep 2006 | - | -$4.14 M(-5.5%) | -$15.66 M(+47.5%) |
| Jun 2006 | - | -$4.39 M(+30.3%) | -$10.61 M(+0.5%) |
| Mar 2006 | - | -$3.37 M(-10.5%) | -$10.56 M(+0.2%) |
| Dec 2005 | -$10.54 M(-20.7%) | -$3.76 M(-517.1%) | -$10.54 M(+8.8%) |
| Sep 2005 | - | $901.50 K(-120.8%) | -$9.69 M(-31.7%) |
| Jun 2005 | - | -$4.34 M(+29.7%) | -$14.20 M(+7.5%) |
| Mar 2005 | - | -$3.35 M(+14.9%) | -$13.21 M(-0.6%) |
| Dec 2004 | -$13.29 M(-7.6%) | -$2.91 M(-19.3%) | -$13.29 M(-7.7%) |
| Sep 2004 | - | -$3.61 M(+7.7%) | -$14.40 M(+4.3%) |
| Jun 2004 | - | -$3.35 M(-2.3%) | -$13.80 M(-1.4%) |
| Mar 2004 | - | -$3.43 M(-14.8%) | -$14.00 M(-2.7%) |
| Dec 2003 | -$14.38 M(+30.9%) | -$4.02 M(+33.7%) | -$14.38 M(+3.6%) |
| Sep 2003 | - | -$3.01 M(-15.1%) | -$13.88 M(+5.6%) |
| Jun 2003 | - | -$3.54 M(-7.0%) | -$13.15 M(+1.7%) |
| Mar 2003 | - | -$3.81 M(+8.0%) | -$12.93 M(+17.7%) |
| Dec 2002 | -$10.98 M(-183.7%) | -$3.52 M(+55.1%) | -$10.98 M(+5.3%) |
| Sep 2002 | - | -$2.27 M(-31.7%) | -$10.43 M(+29.8%) |
| Jun 2002 | - | -$3.33 M(+78.9%) | -$8.04 M(-159.4%) |
| Mar 2002 | - | -$1.86 M(-37.5%) | $13.54 M(+3.3%) |
| Dec 2001 | $13.12 M(-268.1%) | -$2.98 M(-2590.1%) | $13.12 M(-5.5%) |
| Sep 2001 | - | $119.50 K(-99.3%) | $13.88 M(+17.5%) |
| Jun 2001 | - | $18.26 M(-899.0%) | $11.82 M(-248.2%) |
| Mar 2001 | - | -$2.29 M(+3.5%) | -$7.98 M(+2.2%) |
| Dec 2000 | -$7.80 M(-9.3%) | -$2.21 M(+13.3%) | -$7.80 M(+39.4%) |
| Sep 2000 | - | -$1.95 M(+27.0%) | -$5.60 M(+53.4%) |
| Jun 2000 | - | -$1.53 M(-27.3%) | -$3.65 M(+72.7%) |
| Mar 2000 | - | -$2.11 M | -$2.11 M |
| Dec 1999 | -$8.60 M(-62.1%) | - | - |
| Dec 1998 | -$22.68 M(-55.7%) | - | - |
| Dec 1997 | -$51.15 M(+21.4%) | - | - |
| Dec 1996 | -$42.14 M | - | - |
FAQ
- What is Idera Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals annual CFO year-on-year change?
- What is Idera Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals quarterly CFO year-on-year change?
- What is Idera Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals TTM CFO year-on-year change?
What is Idera Pharmaceuticals annual cash flow from operations?
The current annual CFO of IDRA is -$24.60 M
What is the all time high annual CFO for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high annual cash flow from operations is $23.56 M
What is Idera Pharmaceuticals annual CFO year-on-year change?
Over the past year, IDRA annual cash flow from operations has changed by +$9.18 M (+27.17%)
What is Idera Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of IDRA is -$3.20 M
What is the all time high quarterly CFO for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high quarterly cash flow from operations is $35.22 M
What is Idera Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, IDRA quarterly cash flow from operations has changed by +$1.50 M (+31.88%)
What is Idera Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of IDRA is -$15.34 M
What is the all time high TTM CFO for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high TTM cash flow from operations is $23.56 M
What is Idera Pharmaceuticals TTM CFO year-on-year change?
Over the past year, IDRA TTM cash flow from operations has changed by +$12.78 M (+45.45%)